Australian initial public offerings are off to a slow start in 2025 amid concerns US protectionist policies will make assets ...

Die Oldenburgische Landesbank (OLB) hat im vergangenen Jahr offenbar einen Rekordgewinn erzielt. Dahinter standen unter ...

Sunway Healthcare Group has hired banks, including CIMB and Malayan Banking Bhd , to work on a more than 3 billion ringgit ...

Polish medical diagnostics company Diagnostyka has set a maximum price for shares offered in its initial public offering (IPO ...

General Atlantic CEO Bill Ford joins 'Squawk Box' to discuss state of the private equity landscape, IPO market and M&A ...

Mistral, the French AI lab, is working toward an initial public offering, co-founder and CEO Arthur Mensch said in an ...

Zepto is planning to increase its IPO size to between $800 million and $1 billion, including secondary shares, as per The ...

Ascentage is looking to use the IPO proceeds to advance its Phase III candidates for chronic or small lymphocytic leukemia ...

Today’s episode discusses the recovery of global tourism, Hopper’s possible IPO, and the impact of Trump’s orders on tourism.

Naspers' latest results show positive revenue in payments and fintech, but edtech struggles to grow strongly. Read my ...

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases like ulcerative colitis. Read the pre-IPO report here.